Skip to main content

Published locations for Monotherapy or one-two punch against EGFR-mutant NSCLC?

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Monotherapy or one-two punch against EGFR-mutant NSCLC?

User login

  • Reset your password
  • /content/monotherapy-or-one-two-punch-against-egfr-mutant-nsclc
  • /fedprac/article/251231/lung-cancer/monotherapy-or-one-two-punch-against-egfr-mutant-nsclc
  • /internalmedicinenews/article/251231/lung-cancer/monotherapy-or-one-two-punch-against-egfr-mutant
  • /oncologypractice/article/251231/lung-cancer/monotherapy-or-one-two-punch-against-egfr-mutant-nsclc
  • /fedprac/avaho/article/251231/lung-cancer/monotherapy-or-one-two-punch-against-egfr-mutant-nsclc
  • /hematology-oncology/article/251231/lung-cancer/monotherapy-or-one-two-punch-against-egfr-mutant
  • /internalmedicine/article/251231/lung-cancer/monotherapy-or-one-two-punch-against-egfr-mutant-nsclc
  • /chestphysician/article/251231/lung-cancer/monotherapy-or-one-two-punch-against-egfr-mutant-nsclc